{ "company_number": "06612184", "name": "Cubic Pharmaceuticals Limited", "url": "/company/06612184", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2008-06-05", "dissolved_on": null, "sic_codes": [ { "code": "46460", "description": "Wholesale of pharmaceutical goods", "section": "G", "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles", "url": "/sic/46460" } ], "registered_address": { "id": 2397797, "url": "/address/2397797", "line1": "UNIT 3 SEXTANT PARK, NEPTUNE CLOSE", "line2": "MEDWAY CITY ESTATE", "post_town": "ROCHESTER", "county": "KENT", "country": "", "postcode": "ME2 4LU" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06612184", "previous_names": [ { "name": "Cubic Pharmacy Consultants Limited", "ceased_on": "2011-08-15" } ], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-11-30", "last_made_up": "2024-11-30", "category": "MICRO ENTITY", "filings": [ { "url": "/company/06612184/accounts/2024-11-30", "pdf_url": "/company/06612184/accounts/2024-11-30.pdf", "made_up_date": "2024-11-30", "period_start": "2024-11-30", "period_end": "2024-11-30", "entity_name": "Cubic Pharmaceuticals Limited", "dormant": false, "average_employees": "7.00", "tangible_fixed_assets": "2141606.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "195842.00", "creditors_due_within_one_year": "589908.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-393223.00", "total_assets_less_current_liabilities": "1748383.00", "net_assets_liabilities": "1619644.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1619644.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2025.zip" }, { "url": "/company/06612184/accounts/2023-11-30", "pdf_url": "/company/06612184/accounts/2023-11-30.pdf", "made_up_date": "2023-11-30", "period_start": "2023-11-30", "period_end": "2023-11-30", "entity_name": "Cubic Pharmaceuticals Limited", "dormant": false, "average_employees": "9.00", "tangible_fixed_assets": "2143177.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "219409.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "349170.00", "total_assets_less_current_liabilities": "1794007.00", "net_assets_liabilities": "1521544.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1521544.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2024.zip" }, { "url": "/company/06612184/accounts/2021-11-30", "pdf_url": "/company/06612184/accounts/2021-11-30.pdf", "made_up_date": "2021-11-30", "period_start": "2021-11-30", "period_end": "2021-11-30", "entity_name": "Cubic Pharmaceuticals Limited", "dormant": false, "average_employees": "11.00", "tangible_fixed_assets": "1889915.00", "debtors": "230222.00", "cash_bank_in_hand": "190.00", "current_assets": "305412.00", "creditors_due_within_one_year": "329424.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-24012.00", "total_assets_less_current_liabilities": "1865903.00", "net_assets_liabilities": "1369006.00", "called_up_share_capital": "400.00", "profit_loss_account_reserve": "1368606.00", "shareholder_funds": "400.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2022.zip" }, { "url": "/company/06612184/accounts/2020-11-30", "pdf_url": "/company/06612184/accounts/2020-11-30.pdf", "made_up_date": "2020-11-30", "period_start": "2020-11-30", "period_end": "2020-11-30", "entity_name": "Cubic Pharmaceuticals Limited", "dormant": false, "average_employees": "11.00", "tangible_fixed_assets": "1471897.00", "debtors": "249005.00", "cash_bank_in_hand": "66324.00", "current_assets": "415329.00", "creditors_due_within_one_year": "396828.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "18501.00", "total_assets_less_current_liabilities": "1490398.00", "net_assets_liabilities": "1103804.00", "called_up_share_capital": "400.00", "profit_loss_account_reserve": "1103404.00", "shareholder_funds": "400.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2021.zip" }, { "url": "/company/06612184/accounts/2019-11-30", "pdf_url": "/company/06612184/accounts/2019-11-30.pdf", "made_up_date": "2019-11-30", "period_start": "2019-11-30", "period_end": "2019-11-30", "entity_name": "Cubic Pharmaceuticals Limited", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "1119923.00", "debtors": "289927.00", "cash_bank_in_hand": "8927.00", "current_assets": "418854.00", "creditors_due_within_one_year": "559164.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-140310.00", "total_assets_less_current_liabilities": "979613.00", "net_assets_liabilities": "905365.00", "called_up_share_capital": "400.00", "profit_loss_account_reserve": "904965.00", "shareholder_funds": "400.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2020.zip" }, { "url": "/company/06612184/accounts/2018-11-30", "pdf_url": "/company/06612184/accounts/2018-11-30.pdf", "made_up_date": "2018-11-30", "period_start": "2017-12-01", "period_end": "2018-11-30", "entity_name": "Cubic Pharmaceuticals Limited", "dormant": false, "average_employees": "10.00", "tangible_fixed_assets": "718309.00", "debtors": "254688.00", "cash_bank_in_hand": "386.00", "current_assets": "332074.00", "creditors_due_within_one_year": "270667.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "61407.00", "total_assets_less_current_liabilities": "779716.00", "net_assets_liabilities": "683761.00", "called_up_share_capital": "400.00", "profit_loss_account_reserve": "683361.00", "shareholder_funds": "400.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "298256.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2019.zip" }, { "url": "/company/06612184/accounts/2017-11-30", "pdf_url": "/company/06612184/accounts/2017-11-30.pdf", "made_up_date": "2017-11-30", "period_start": "2016-12-01", "period_end": "2017-11-30", "entity_name": "Cubic Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "385245.00", "debtors": "138948.00", "cash_bank_in_hand": "10427.00", "current_assets": "259375.00", "creditors_due_within_one_year": "259115.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "260.00", "total_assets_less_current_liabilities": "385505.00", "net_assets_liabilities": "385505.00", "called_up_share_capital": "400.00", "profit_loss_account_reserve": "385105.00", "shareholder_funds": "400.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "188111.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2018.zip" }, { "url": "/company/06612184/accounts/2016-11-30", "pdf_url": "/company/06612184/accounts/2016-11-30.pdf", "made_up_date": "2016-11-30", "period_start": "2016-11-30", "period_end": "2016-11-30", "entity_name": "Cubic Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "188590.00", "debtors": "214999.00", "cash_bank_in_hand": "2708.00", "current_assets": "265270.00", "creditors_due_within_one_year": "407177.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-141907.00", "total_assets_less_current_liabilities": "46683.00", "net_assets_liabilities": "46683.00", "called_up_share_capital": "400.00", "profit_loss_account_reserve": "46283.00", "shareholder_funds": "46683.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2017.zip" }, { "url": "/company/06612184/accounts/2015-11-30", "pdf_url": "/company/06612184/accounts/2015-11-30.pdf", "made_up_date": "2015-11-30", "period_start": "2015-11-30", "period_end": "2015-11-30", "entity_name": "Cubic Pharmaceuticals Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "195386.00", "debtors": "213554.00", "cash_bank_in_hand": "951.00", "current_assets": "320318.00", "creditors_due_within_one_year": "435095.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-114777.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "80609.00", "called_up_share_capital": "300.00", "profit_loss_account_reserve": "80309.00", "shareholder_funds": "80609.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2016.zip" }, { "url": "/company/06612184/accounts/2014-11-30", "pdf_url": "/company/06612184/accounts/2014-11-30.pdf", "made_up_date": "2014-11-30", "period_start": "2014-11-30", "period_end": "2014-11-30", "entity_name": "Cubic Pharmaceuticals Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "36779.00", "debtors": "143944.00", "cash_bank_in_hand": "167.00", "current_assets": "179901.00", "creditors_due_within_one_year": "213582.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-33681.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "3098.00", "called_up_share_capital": "300.00", "profit_loss_account_reserve": "2798.00", "shareholder_funds": null, "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2015.zip" }, { "url": "/company/06612184/accounts/2013-11-30", "pdf_url": "/company/06612184/accounts/2013-11-30.pdf", "made_up_date": "2013-11-30", "period_start": "2013-11-30", "period_end": "2013-11-30", "entity_name": "Cubic Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "29539.00", "debtors": "158511.00", "cash_bank_in_hand": "3143.00", "current_assets": "194184.00", "creditors_due_within_one_year": "84356.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "109828.00", "total_assets_less_current_liabilities": "139367.00", "net_assets_liabilities": "139367.00", "called_up_share_capital": "300.00", "profit_loss_account_reserve": "139067.00", "shareholder_funds": "139367.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2014.zip" }, { "url": "/company/06612184/accounts/2012-11-30", "pdf_url": "/company/06612184/accounts/2012-11-30.pdf", "made_up_date": "2012-11-30", "period_start": "2012-11-30", "period_end": "2012-11-30", "entity_name": "Cubic Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "7037.00", "debtors": "86113.00", "cash_bank_in_hand": "31009.00", "current_assets": "144452.00", "creditors_due_within_one_year": "44671.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "99781.00", "total_assets_less_current_liabilities": "106818.00", "net_assets_liabilities": "106818.00", "called_up_share_capital": "300.00", "profit_loss_account_reserve": "106518.00", "shareholder_funds": "106818.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2013.zip" }, { "url": "/company/06612184/accounts/2011-11-30", "pdf_url": "/company/06612184/accounts/2011-11-30.pdf", "made_up_date": "2011-11-30", "period_start": "2011-11-30", "period_end": "2011-11-30", "entity_name": "Cubic Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "4201.00", "debtors": "137211.00", "cash_bank_in_hand": "6128.00", "current_assets": "207469.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "99037.00", "total_assets_less_current_liabilities": "103238.00", "net_assets_liabilities": "103238.00", "called_up_share_capital": "300.00", "profit_loss_account_reserve": "102938.00", "shareholder_funds": "103238.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2012.zip" }, { "url": "/company/06612184/accounts/2010-11-30", "pdf_url": "/company/06612184/accounts/2010-11-30.pdf", "made_up_date": "2010-11-30", "period_start": "2010-11-30", "period_end": "2010-11-30", "entity_name": "Cubic Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "547.00", "debtors": "266257.00", "cash_bank_in_hand": "23360.00", "current_assets": "317937.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "101820.00", "total_assets_less_current_liabilities": "102367.00", "net_assets_liabilities": "102367.00", "called_up_share_capital": "300.00", "profit_loss_account_reserve": "102067.00", "shareholder_funds": "102367.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2011.zip" }, { "url": "/company/06612184/accounts/2009-11-30", "pdf_url": "/company/06612184/accounts/2009-11-30.pdf", "made_up_date": "2009-11-30", "period_start": "2009-11-30", "period_end": "2009-11-30", "entity_name": "Cubic Pharmacy Consultants Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "729.00", "debtors": "52360.00", "cash_bank_in_hand": "57276.00", "current_assets": "152686.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "50765.00", "total_assets_less_current_liabilities": "51494.00", "net_assets_liabilities": "51494.00", "called_up_share_capital": "300.00", "profit_loss_account_reserve": "51194.00", "shareholder_funds": "51494.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2010.zip" } ], "pdf_only_filings": [ { "made_up_date": "2022-11-30", "filing_date": "2023-09-29", "form_type": "AA", "description": "accounts-with-accounts-type-unaudited-abridged", "paper_filed": null, "pdf_url": "/company/06612184/accounts/2022-11-30.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06612184/filing-history/MzM5NDg5Nzc5OWFkaXF6a2N4/document?format=pdf&download=0" } ], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/06612184/filing-history" }, "confirmation_statement": { "next_due": "2026-11-25", "last_made_up": "2025-11-11" }, "officers": [], "psc": [ { "name": "Anwar Ali", "kind": "individual-person-with-significant-control", "person_url": "/person/498884", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2017-06-01", "ceased_on": null, "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Saumil Kiritkumar Bhatt", "kind": "individual-person-with-significant-control", "person_url": "/person/4521796", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2017-06-01", "ceased_on": null, "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Arun Jangra", "kind": "individual-person-with-significant-control", "person_url": "/person/526038", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2017-06-01", "ceased_on": null, "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-09-01", "retrieved_at": "2026-09-20T03:23:56.377763+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }